1. Home
  2. LYEL vs FIRY Comparison

LYEL vs FIRY Comparison

Compare LYEL & FIRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$9.34

Market Cap

195.8M

Sector

Health Care

ML Signal

HOLD

Logo Firy Inc. Class A Common Stock

FIRY

Firy Inc. Class A Common Stock

HOLD

Current Price

$11.72

Market Cap

190.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYEL
FIRY
Founded
2018
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
195.8M
190.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
LYEL
FIRY
Price
$9.34
$11.72
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $37.88
N/A
AVG Volume (30 Days)
★ 151.7K
129.6K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
$36,000.00
★ $104,496,000.00
Revenue This Year
N/A
$22.11
Revenue Next Year
N/A
$7.99
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 12.52
52 Week Low
$7.20
$7.92
52 Week High
$45.00
$14.12

Technical Indicators

Market Signals
Indicator
LYEL
FIRY
Relative Strength Index (RSI) 47.13 52.23
Support Level $7.20 $9.31
Resistance Level $15.38 $14.02
Average True Range (ATR) 0.73 0.68
MACD 0.26 -0.19
Stochastic Oscillator 76.41 53.88

Price Performance

Historical Comparison
LYEL
FIRY

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.

About FIRY Firy Inc. Class A Common Stock

Firy Inc, formerly Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. Its reportable segments are: the Skillz segment and the RZR segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is a performance marketing platform that enables advertisers to acquire, retain, and monetize users across mobile, connected television (CTV), and other digital channels. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube, among others. It generates the majority of its revenue from the Skillz segment. Geographically, the company derives its key revenue from the United States.

Share on Social Networks: